An Open-Label Multidose Psilocybin Intervention for Obsessive-Compulsive Disorder
Preprint, not peer reviewed. Tiwari P, Nayak SM, Sepeda ND et al.. medRxiv, 5 Oct 2026.
Tags: Human, Preprint, Psilocybin, Depression, Anxiety, OCD.
waitlist-controlled open-label multidose psilocybin in 30 treatment-resistant OCD patients at Johns Hopkins; feasibility and safety first, efficacy unblinded
How much weight it carries: Not peer reviewed. Early results that may not hold up. (Preprint)
Read the original
